Neurocrine Biosciences Inc vs Shopify Inc. — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Shopify Inc. trades at $122.75 (market cap $161.53B). The key difference: Shopify Inc. is far larger — about 9.3× Neurocrine Biosciences Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Shopify Inc. nearer its low. Which is the better fit depends on your goals.
| NBIX | SHOP | |
|---|---|---|
Market Cap | $17.40B | $161.53B |
Sector | Health | Technology |
52-Week High | $180.55 | $179.01 |
52-Week Low | $123.10 | $95.40 |
Enterprise Value | $16.49B | $155.97B |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →